Cuprous Ions Binding to Cytosine and Guanine Oligonucleotides
Joana Pereira, Mathilde Brachet, Philippe Barthélémy, Bruno Aliès
0 citationsChemBioChem
Philippe Barthélémy
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
553Publications signalées
15169Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
Renal cell carcinoma treatmentRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesCancer Immunotherapy and BiomarkersProstate Cancer Treatment and Research
Publications récentes
Novel Chitosan Bioink Derived from Eurycantha calcarata (Lucas, 1869) for 3D Bioprinting of Cell-Compatible Scaffolds
Zhenying Mei, Julie Lagouarde, Olga Volkova, Virginie Baylot et autres
0 citationsACS Omega
Using DNA Origami to Study Nanoscale Organization of Plasma Membranes
Eloina Corradi, Konlin Shen, Zeynep Karatas, Maureen Cercy et autres
0 citationsNano Letters
Bioinspired nucleolipid as a low molecular weight oleogelator for oil-in-water nanoemulsions
Arthur Klufts-Edel, Berangere Dessane, Ahmad Saad, Nadia El Mammeri et autres
1 citationMolecular Systems Design & Engineering
Correction: Control of cancer cell phenotypes via supramolecular hydrogels: the role of extracellular matrix stiffness
Virginie Baylot, Bruno Aliès, Palma Rocchi, Philippe Barthélémy
0 citationsMaterials Advances
Accelerating recruitment in clinical trials: A strategic challenge
Dominique Deplanque, Ariane Galaup, Christine Trillou, Philippe Barthélémy et autres
0 citationsTherapies
First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer
Simon Nannini, Fabien Moinard‐Butot, Sylvain Ladoire, Dorian Bochaton et autres
0 citations
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)
Alicia K. Morgans, Alex Chehrazi‐Raffle, Tamim Niazi, Neal D. Shore et autres
3 citationsFuture Oncology
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study
Ronan Flippot, Yann Vano, Cécile Dalban, Benoit Beuselinck et autres
1 citationEuropean Urology
First-line treatment selection in metastatic Urothelial Carcinoma (mUC) in the new Enfortumab Vedotin-Pembrolizumab (EV-P) Era: Is there still a place for alternative regimens? Results from the FLORAL real-world study
Fabien Moinard‐Butot, H. Berthou, Jonathan Thouvenin, Sophie Tartas et autres
0 citationsEuropean Urology Open Science
Efficacy of Enfortumab-Vedotin (EV) in patients (pts) with advanced or metastatic urothelial carcinoma (UC) with histological variants: EV-VISIBLE trial
Clara Vacheret, Fabien Moinard‐Butot, D. Teyssoneau, Karim Amrane et autres
0 citationsEuropean Urology Open Science
Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
Chaïma Cherif, Dang Tan Nguyen, Clément Paris, Thi Khanh Le et autres
0 citationsOncogene
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.